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Abstract
Background: This study aimed to evaluate the still unknown factors correlating with the degree
of nerve involvement in early Bell's palsy.
Methods: This retrospective chart review study of newly diagnosed cases of Bell's palsy was
conducted over a three-year period. Information on age, sex, day of onset, comorbidities,
corticosteroid use, and electroneurographic test results were collected. The electroneurographic
quotient (amplitude of compound muscle action potential on the affected side divided by that on
the healthy side and expressed in percent) was used as an index of nerve involvement, with lower
quotient indicating more severe disease.
Results: Data were collected on 563 patients. The mean electroneurographic quotient varied
inversely with age (p < 0.001) and was higher in patients who used corticosteroids than those who
did not (47.1% vs. 40.3%; p = 0.002). There was no correlation between the degree of nerve
involvement and sex, season of onset, hypertension, or diabetes.
Conclusion: The degree of nerve involvement in early Bell's palsy correlates positively with age
and negatively with corticosteroid use.
Background
A concern of both patients with Bell's palsy and their phy-
sicians is when and how facial paralysis will be completely
resolved [1]. Many previous studies have focused on the
long-term prognosis of Bell's palsy [1-8]. Systems for clin-
ically assessing prognosis include the House-Brackmann
facial nerve grading system, Yanagihara scoring system,
nerve excitability test, electroneurography, electromyogra-
phy, blink reflex, stapedial muscle reflex, prediction equa-
tions using combinations of these, brain magnetic
resonance imaging, and even a novel 3-dimensional real-
time video acquisition system [1-3,7-12]. Of these, elec-
troneurography is the most frequently used because it
provides objective, quantitative, and accurate data for
assessing facial nerve function [1,6]. It measures and
records the amplitudes of muscle summation potentials
resulting from the synchronous firing of motor units [6].
A percent of nerve fibers that are neuropraxic is obtained
by comparing the amplitude of the compound muscle
action potentials on the affected side with that on the
healthy side [8,13].
Electroneurography has been used in many clinical stud-
ies to evaluate compound action potentials, nerve con-
duction velocities, and distal motor conduction latencies
on two sides of the face [14-16] and thereby to detect
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early-stage conditions involving neural damage. The pur-
pose of these studies was mainly to predict long-term fol-
low-up prognosis and select subjects for treatment [17].
Long-term prognostic studies of Bell's palsy have shown
that recovery rate in older individuals is poor [1,5,18].
Unlike the study of Salinas et al [19], many studies show
usage of corticosteroids improves the prognosis of Bell's
palsy [4,10,16,20-22]. Nearly everyone agrees that mild
early Bell's palsy carries a better long-term prognosis.
However, indicators of the degree of nerve involvement in
early Bell's palsy are unknown. Therefore, our aim was to
evaluate potential factors (age, sex, hypertension, diabetes
mellitus, season of onset, and corticosteroid use) as corre-
lates of the degree of nerve involvement in early Bell's
palsy.
Methods
This retrospective chart review study was of cases of Bell's
palsy newly diagnosed between 2003 and 2005 at Shin
Kong Wu Ho-Su Memorial Hospital (a teaching hospital
in Taipei, Taiwan). The Bell's palsy diagnostic criteria were
acute onset of lower motor neuron facial palsy unaccom-
panied by evidence of traumatic, vascular, oncologic, or
other infectious etiologies ruled out by aural, neurologic,
or clinical examination [23]. The research ethics commit-
tee of the hospital approved the study protocol. Data on
age, sex, day of onset, comorbidities (e.g., hypertension,
diabetes mellitus, hepatic disease, renal disease, and car-
diovascular disease), corticosteroid use, and treatment
with acyclovir post-diagnosis were collected. Electroneu-
rographic studies were performed 10–15 days after disease
onset using a 2-channel Medelec™ Synergy N-EP – EMG/
EP Monitoring System (Oxford Instruments Medical,
Oxford, UK). Facial nerves were stimulated bilaterally
with bipolar surface electrodes placed over the stylomas-
toid foramen and their responses were recorded from elec-
trodes placed over the orbicularis oculi muscles. Maximal
compound muscle action potentials were obtained by
gradually increasing the intensity of the stimulus to
supramaximal levels [13]. An electroneurographic quo-
tient, defined as the ratio of the amplitude of compound
muscle action potential on the affected side to that on the
healthy side [7], was calculated (as a percent) and served
as the index of degree of nerve involvement. A lower elec-
troneurographic quotient indicates more severe disease.
The chi-square test was used for statistical analysis of cat-
egorical variables and Student's t test or analysis of vari-
ance was used for continuous variables. A difference was
considered significant at a p-value of less than 0.05. Cor-
relates of electroneurographic quotient were analyzed by
multiple regression analysis.
Results
A total of 787 cases of Bell's palsy were reviewed. Twelve
cases of recurrent Bell's palsy and 212 cases without elec-
troneurographic test data were excluded. Data from a total
of 563 cases (319 men; 244 women) were included. The
age distribution in years was 0–90 with 33 patients (aged
0–20), 102 (aged 21–30), 104 (aged 31–40), 105 (aged
41–50), 98 (aged 51–60), 73 (aged 61–70), and 48 (71–
90). The season of disease onset was spring (for 115
patients), summer (114), autumn (145), and winter
(159). A total of 61 patients (10.8%) had hypertension,
38 (6.7%) had diabetes mellitus, and 24 (4.3%) had both.
Corticosteroids were used by 347 (61.6%) patients and 11
patients used both corticosteroids and antiviral drugs at
the same time. The demographics were similar between
excluded patients without electroneurographic data and
included patients with electroneurographic data. More
women than men underwent electroneurographic studies.
The correlation of electroneurographic quotient with
study variables is shown in Table 1. Electroneurographic
quotients decreased significantly with increase in age (p <
0.001), indicating more severe disease occurred in older
patients (Table 1, Figure 1). Patients who used corticoster-
oids had better (i.e., higher) electroneurographic quo-
tients than those who did not (47.1% vs. 40.3%, p  =
0.002). Electroneurographic quotient was not correlated
with sex, season of onset, hypertension, or diabetes melli-
tus. Multiple regression analysis showed a decrease in
electroneurographic quotient of 2.78 (p < 0.001) per 10-
year increase in age, and an increase in electroneuro-
graphic quotient of 5.47 (p = 0.010) in patients treated
with corticosteroids.
Discussion
Following complete transection of the facial nerve, Walle-
rian degeneration starts in 3–5 days and maximal injury
usually occurs within 1–2 weeks [3,7,8,24]. For this rea-
son, most clinical neurophysiologists recommend carry-
ing out electromyographic and electroneurographic
studies 10–15 days after the onset of facial weakness in
Bell's palsy to determine the magnitude of axonal damage
to the facial nerves [25]. Since this time window (10–15
days after onset of Bell's palsy, which is coincident with
axonal degeneration in early Bell's palsy) was routinely
used in our hospital, we were able to obtain the data
needed to examine the correlation of electroneurographic
quotient with possible prognostic factors.
Older patients with Bell's palsy have poor prognoses
[1,5,18]. Our study showed that the degree of nerve
involvement in early Bell's palsy increased with increasing
age. Less severe nerve damage in younger patients could
also be due to early use of corticosteroids. To avoid this
bias, patients were stratified according to corticosteroids
use for further analysis. The correlation of electroneuro-
graphic quotient with age was -0.223 (p < 0.001) in 347
patients treated with corticosteroids, and -0.159 (p  =
0.019) in 216 patients without corticosteroids therapy,BMC Neurology 2009, 9:22 http://www.biomedcentral.com/1471-2377/9/22
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indicating that the degree of nerve involvement was nega-
tively correlated with age, irrespective of corticosteroids
use.
Aging diminishes the capacity for neural regeneration [5].
This could be due to glial cell hyperactivity and an aging-
related increase in brain cytokine activity that impairs the
ability of cells to repair themselves [26]. Animal studies
show that aging is associated with increased reactivity of
astrocytes and decreased post-lesion sprouting capability
[27]. In addition, the basal level of intracellular calcium in
older animals is increased, which decreases neural net-
work efficiency [28]. All of these factors could contribute
to the more severe facial nerve damage in older patients
[29].
Our study showed that use of corticosteroids decreased
the degree of nerve involvement in early Bell's palsy.
While the dosages and durations varied, corticosteroid
therapy was started within 3 days of onset in most cases.
Although some older studies report equivocal findings,
more recent studies show that early corticosteroid treat-
ment of Bell's palsy (within 3 days, and up to 7 days from
onset) improves long-term recovery [16,22,30,31].
Although electroneurographic studies performed 10–15
days after onset could be affected by differences in corti-
costeroid dosage and duration, on average, electroneuro-
graphic quotient was 7% higher in patients who used
corticosteroids.
In this study, 61.6% of patients received corticosteroid
therapy. The corticosteroid-treated group had more men
(p = 0.030) than women and were younger (p = 0.040)
than the group that did not receive corticosteroids. Since
gender had no effect on the relationship of electroneuro-
graphic quotient to degree of nerve involvement, the pres-
ence of a greater number of corticosteroid-treated male
patients did not confound our analysis. Nonetheless, this
retrospective study could not avoid bias that could arise
from the possible preferred use of corticosteroids in
younger and healthier patients because corticosteroids
have fewer contraindications in younger and healthier
patients. On the other hand, patients might be given cor-
ticosteroids because they were more severely affected.
Then, the observed difference in electroneurographic quo-
tients in this study may underestimate the effect of corti-
costeroid therapy. Also, because this is not a randomized
study, it remains unclear whether the higher electroneuro-
graphic quotient detected in the corticosteroid group is
attributable to spontaneous remission or to actual thera-
peutic effects of corticosteroids.
Although Merwarth [32] suggested that hypertension
increased the incidence of bleeding within the fallopian
canal and facial nerve compression, the relationship
between hypertension and the severity of Bell's palsy
remains controversial [5]. We found borderline signifi-
cant correlation between the electroneurographic quo-
tient and hypertension (p = 0.050). Further, hypertension-
stratified analysis of electroneurographic quotient showed
that corticosteroid-treated subjects with hypertension had
significantly better electroneurographic quotients than
corticosteroid-treated subjects without hypertension
(54.9% vs. 46.2%, p = 0.044). Electroneurographic quo-
tient was negatively correlated with age (correlation coef-
ficient, -0.0065; p < 0.0001) in non-hypertensive patients.
Electroneurographic quotient was not correlated with
gender in our hypertensive group. Nonetheless, the
number of subjects with hypertension in our study (n =
61) was small, and therefore generalization to larger
patient populations might be unwarranted. Our results
were similar to those of a previous study reporting no
definitive correlation between diabetes mellitus and
severity of Bell's palsy [5].
Fisch et al. found that when the electroneurographic quo-
tient was more than 10% (i.e., the extent of facial nerve
degeneration was less than 90%), all patients recovered
fully; when it was 5%, half of patients had a poor recovery
on long-term follow up [2,3,6,7]. In contrast, May and
Chow found that if the electroneurographic quotient was
27–30%, patients had an 84–90% chance of a good recov-
ery [8,33]. Although long-term prognostic results of elec-
troneurographic quotient differed due to variations in the
studied populations [24], the electroneurographic quo-
tient correlated well with the degree of nerve involvement
in early Bell's palsy [1,6,8].
The correlation of electroneurographic quotient (ENGQ)  with age Figure 1
The correlation of electroneurographic quotient 
(ENGQ) with age. Electroneurographic quotient 
decreased significantly with increase in age (p < 0.001).BMC Neurology 2009, 9:22 http://www.biomedcentral.com/1471-2377/9/22
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In our study, electroneurographic quotient was used as an
index of nerve involvement in early Bell's palsy. The facial
nerve contains about 10,000 fibers [3]. The amplitude of
compound muscle action potential is measured peak-to-
peak in micro volts [3]. Many factors such as electrode
placement, electrode application pressure, skin resistance,
and stimulating current affect electroneurographic study
results [1,34]. Variation in electroneurography of 3–5.4%
between the two sides of the face (i.e., right side vs. left
side) and 10% between tests [35,36] has been reported. In
our hospital, all electroneurographic studies were per-
formed in two electrodiagnostic laboratories by skilled
technicians in the Department of Neurology and by phy-
siatrists in the Department of Physical Medicine and
Rehabilitation. Therefore, we believe that the possible
small variations in electroneurographic studies have not
adversely affected our findings.
This retrospective study had some limitations, such as dif-
ferences between subgroups, small size of some subgroup
samples, and bias of administering corticosteroids mainly
to younger subjects. In addition, this study lacks measure-
ments of long-term clinic outcome. In the 563 subjects,
the average number of clinic visits was 3.5 (ranging from
only one visit in 13 subjects to a maximum of 27 visits),
with a mean of 53.3 days (ranging from 0 days to 2.9
years) of follow up. These subjects mainly visited depart-
ments of neurology, otolaryngology, physical medicine
and rehabilitation, and some visited departments of fam-
ily medicine and internal medicine. Although nearly all
subjects showed fair to good recovery by clinical physical
and neurological examination recorded by the diagnosing
and treating physicians, no uniform objective clinical
measurements were used. Therefore, our data can not be
used to identify correlates with long-term prognosis.
Conclusion
We assessed the factors correlating with the degree of
nerve involvement in early Bell's palsy. We found a posi-
tive correlation with age and negative correlation with
corticosteroids use. However, this was a retrospective
study. To evaluate the relationship of corticosteroid ther-
apy to the degree of nerve involvement in early Bell's
palsy, future prospectively randomized studies of corticos-
teroid therapy with an appropriate method (e.g., clinical
scores) are essential.
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Table 1: The correlation of electroneurographic quotient with clinical and demographic features in 563 subjects with Bell's palsy.
Variables Electroneurographic quotient mean(SD) p value
Sex
Men 44.3 (24.6) 0.77
Women 44.9 (24.9)
Age (in years)
0–10 59.8 (15.0) <0.001**
11–20 54.6 (26.3)
21–30 60.0 (23.8)
31–40 47.5 (24.8)
41–50 43.2 (24.6)
51–60 40.4 (21.9)
61–70 39.5 (26.9)
71–80 36.6 (23.5)
81–90 31.3 (25.1)
Onset season
Spring 46.1 (24.5) 0.676
Summer 55.0 (24.0)
Autumn 45.7 (24.4)
Winter 43.1 (26.0)
Hypertension
yes 50.4 (26.2) 0.05
no 43.8 (24.5)
Diabetes mellitus
yes 45.3 (27.7) 0.835
no 44.5 (24.5)
Corticosteroid use
yes 47.1 (24.2) 0.002*
no 40.3 (25.1)
*p < 0.005, **p < 0.001Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Neurology 2009, 9:22 http://www.biomedcentral.com/1471-2377/9/22
Page 5 of 5
(page number not for citation purposes)
Authors' contributions
RLH carried out the design of the study and drafted the
manuscript. CWW participated in the design of study and
data collection. LYW participated in the design of the
study and performed the statistical analysis. WCL partici-
pated in the study of design and coordination. All authors
read and approved the final manuscript.
Acknowledgements
This study was supported in part by a research grant (SKH-8302-95-DR-
42) from the Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan, and 
also from the National Science Council, Taipei, Taiwan.
References
1. Ushino M, Kondo K, Takeuchi N, Tojima H, Yamaguchi T, Kaga K:
Prediction of the prognosis of Bell's palsy using multivariate
analyses.  Otol Neurotol 2007, 29:69-72.
2. Fisch U: Prognostic value of electrical tests in acute facial
paralysis.  Am J Otol 1984, 5:494-498.
3. Hughes GB: Prognostic tests in acute facial palsy.  Am J Otol
1989, 10:304-311.
4. Adour KK, Hetzler DG: Current medical treatment for facial
palsy.  Am J Otol 1984, 5:499-502.
5. Smith IM, Heath JP, Murray JAM, Cull RE: Idiopathic facial (Bell's)
palsy: a clinical survey of prognostic factors.  Clin Otolaryngol
1988, 13:17-23.
6. Smith IM, Maynard C, Mountain RE, Barr-Hamilton R, Armstrong M,
Murray AM: The prognostic value of facial electroneurogra-
phy in Bell's palsy.  Clin Otolaryngol Allied Sci 1994, 19:201-203.
7. Gantz BJ, Rubinstein JT, Gidley P, Woodworth GG: Surgical man-
agement of Bell's palsy.  Laryngoscope 1999, 109:1177-1188.
8. Chow LCK, Tam RCN, Li MF: Use of electroneurography as a
prognostic indicator of Bell's palsy in Chinese patients.  Otol
Neurotol 2002, 23:598-601.
9. de Ru JA, Braunius WW, van Benthem PP, Busschers WB, Hordijk GJ:
Grading facial nerve function: why a new grading system, the
MoReSS, should be proposed.  Otol Neurotol 2006, 27:1030-1036.
10. Hato N, Yamada H, Kohno H, Matsumoto S, Honda N, Gyo K,
F u k u d a  S ,  F u r u t a  Y ,  O h t a n i  F ,  A i z a w a  H ,  A o y a g i  M ,  I n a m u r a  H ,
Nakashima T, Nakata S, Murakami S, Kiguchi J, Yamano K, Takeda T,
Hamada M, Yamakawa K: Valacyclovir and prednisolone treat-
ment for Bell's palsy: a multicenter, randomized, placebo-
controlled study.  Otol Neurotol 2007, 28:408-413.
11. Mehta RP, Zhang S, Hadlock TA: Novel 3-D video for quantifica-
tion of facial movement.  Otolaryngol Head Neck Surg 2008,
138:468-472.
12. Seok JI, Lee DK, Kim KJ: The usefulness of clinical findings in
localizing lesions in Bell's palsy: comparison with MRI.  J Neu-
rol Neurosurg Psychiatry 2008, 79:418-420.
13. Bagger-Sjöbäck D, Remahl S, Ericsson M: Long-term outcome of
facial palsy in neuroborreliosis.  Otol Neurotol 2005, 26:790-795.
14. Sinha PK, Keith RW, Pensak ML: Predictability of recovery from
Bell's palsy using evoked electromyography.  Am J Otol 1994,
15:769-771.
15. Jori J, Szekely L, Kiss JG, Toth F: The prognostic value of facial
nerve conduction velocity in patients with Bell's palsy.  Clin
Otolaryngol Allied Sci 1998, 23:520-523.
16. Vargish L, Schumann SA: For Bell's palsy, start steroids early; no
need for an antiviral.  J Fam Practice 2008, 57:22-25.
17. Adour KK, Hilsinger RL Jr, Callan EJ: Facial paralysis and Bell's
palsy: a protocol for differential diagnosis.  Am J Otol
1985:68-73.
18. Ikeda M, Abiko Y, Kukimoto N, Omori H, Nakazato H, Ikeda K: Clin-
ical factors that influence the prognosis of facial nerve paral-
ysis and the magnitude of influence.  Laryngoscope 2005,
115:855-860.
19. Salinas RA, Alvarez G, Ferreira J: Corticosteroids for Bell's palsy
(idiopathic facial paralysis).  Cochrane Database Syst Rev 2004,
18:CD001942.
20. Adour KK, Wingerd J, Bell DN, Manning JJ, Hurley JP: Prednisone
treatment for idiopathic facial paralysis (Bell's palsy).  New
Engl J Med 1972, 287:1268-1272.
21. Austin JR, Peskind SP, Austin SG, Rice DH: Idiopathic facial nerve
paralysis: a randomized double blind controlled study of pla-
cebo versus prednisone.  Laryngoscope 1993, 103:1326-1333.
22. Piercy J: 10-minute consultation: Bell's palsy.  BMJ 2005,
330:1374.
23. Kannikeswaran N, Mahajan PV, Kamat D: Acute facial asymmetry.
Clin Pediatr 2006, 45:289-292.
24. Kerbavaz RJ, Hilsinger RL, Adour KK: The facial paralysis prog-
nostic index.  Otolaryngol Head Neck Surg 1983, 91:284-289.
25. Aramimed M, Valls-Sole J, Cruccu G, Ongerboer de Visseret BW:
Disorders of the Cranial Nerves.  In Neuromuscular Function and
Disease: Basic, Clinical, and Electrodiagnostic Aspects Volume 1. 1st edi-
tion. Edited by: Brown WF, Bolton CF, Aminoff MJ. Philadelphia: W.B.
Saunders Company; 2002:761. 
26. Hurley SD, Coleman PD: Facial nerve axotomy in aged and
young adult rats: analysis of the glial response.  Neurobiol Aging
2003, 24:511-518.
27. Nacimiento W, Brook GA, Noth J: Lesion-induced neuronal
reorganization in the spinal cord: morphological aspects.  Adv
Neurol 1997, 73:37-59.
28. Kostyuk PG: Plasticity in nerve cell function.  In Monographs of
the Physiological Society Oxford: Oxford Medical Publications: Claren-
don Press; 1998:66-82. 
29. Kiziltan ME, Uzun N, Kiziltan G, Savrun FK: The influence of age in
peripheral facial palsy on brainstem reflex excitability.  Neurol
India 2005, 53:318-322.
30. Gilden DH, Tyler KL: Bell's palsy-is glucocorticoid treatment
enough?  New Engl J Med 2007, 357:1653-1655.
31. Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry
B, Davenport RJ, Vale LD, Clarkson JE, Hammersley V, Hayavi S, McA-
teer A, Stewart K, Daly F: Early treatment with prednisolone or
acyclovir in Bell's palsy.  New Engl J Med 2007, 357:1598-1607.
32. Merwarth HR: The occurrence of peripheral facial paralysis in
hypertensive vascular disease.  Ann Intern Med 1942, 17:298-307.
33. May M, Blumenthal F, Klein SR: Acute Bell's palsy: prognostic
value of evoked electromyography maximal stimulation and
other electrical tests.  Am J Otol 1983, 5:1-7.
34. Hsieh RL: Re: Cutaneous electrical stimulation in unresolved
facial nerve paralysis.  Am J Phys Med Rehabil  in press.
35. Gantz BJ, Gmuer AA, Holliday M, Fisch U: Electroneurographic
evaluation of the facial nerve: method and technical prob-
lems.  Ann Otol Rhinol Laryngol 1984, 93:394-398.
36. Silverstein H, McDaniel AB, Hyman SM: Evoked serial electromy-
ography in the evaluation of the paralyzed face.  Am J Otol
1985:80-87.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2377/9/22/prepub